Taylor Harris, Ph.D.

Taylor Harris is an equity research analyst primarily focused on immuno-oncology, cell therapy, and neurodegeneration. Taylor received her bachelor of science in biomedical engineering from the University of North Carolina. She recently received her doctorate degree in biomedical engineering from Washington University in St. Louis where she also obtained her master’s degree in the same discipline. Her graduate work was conducted in the Orthopedic Surgery Department at Washington University School of Medicine, investigating the cellular mechanisms for bone formation in the context of osteoporosis which resulted in several publications. During her graduate career, she worked at Kennedy Capital as a biotech equity research fellow where she gained experience in finance and security analysis. Taylor also served as Director of Operations for the Biotechnology and Life Sciences Advising (BALSA) group, a consulting firm in St. Louis.